Rate of recording of selected CTV3 codes and groups of codes for each topic in February, April, and December 2020. Clinical topics include: a) cardiovascular disease; b) diabetes; c) mental health; d) female and reproductive health; e) screening and related procedures; and f) processes related to medication. Table shows median rate across general practices in England per 1000 registered patients and % change on the same month in previous year. Further detailed breakdowns of code recording are shown in Supplementary Tables S2a–S2f
| Topic | CTV3 code/group | Median rate per 1000 registered patients (% change on previous year) | ||
|---|---|---|---|---|
| February | April | December | ||
| a) CVD | 24 — ‘Examination of cardiovascular system’ | 164.2 | 19.8 (−86.9%) | 82.6 (−42.6%) |
| 18 — ‘Cardiovascular symptoms (and [heart])’ | 0.6 | 0.3 (−57.1%) | 0.4 (−17.7%) | |
| G5 — ‘Other forms of heart disease’ | 0.5 | 0.3 (−48.9%) | 0.4 (−6.4%) | |
| XaQVY — ‘QRISK2 cardiovascular disease 10 year risk score’ | 6.9 | 0.6 (−98.3%) | 3.0 (−38.9%) | |
| XaKFx — ‘Average home systolic blood pressure’ | 0.4 | 0.2 (−8.1%) | 0.7 (+102.8%) | |
| XaKFw — ‘Average home diastolic blood pressure’ | 0.4 | 0.2 (−8.3%) | 0.6 (+98.0%) | |
| b) Diabetes | 66A — ‘Diabetic monitoring’ | 4.6 | 0.4 (−87.5%) | 3.3 (−16.6%) |
| XaPbt — ‘Haemoglobin A1c level — IFCC standardised’ | 28.2 | 3.4 (−86.2%) | 22.4 (−0.6%) | |
| XaIIj — ‘Diabetic retinopathy screening’ | 1.8 | 0.0 (−100.0%) | 0.7 (−53.7%) | |
| XaIeH — ‘O/E — Right diabetic foot at low risk’ | 3.8 | 0.0 (−100.0%) | 2.7 (−18.0%) | |
| XaIuE — ‘Diabetic foot examination’ | 0.2 | 0.0 (−100.0%) | 0.2 (+113.8%) | |
| c) Mental health | E2 — ‘Neurotic, personality, and other nonpsychotic disorders’ | 1.2 | 0.6 (−44.5%) | 0.8 (−23.7%) |
| E20 — ‘Neurotic disorder’ | 0.8 | 0.5 (−39.1%) | 0.5 (−21.9%) | |
| XaK6f — ‘Depression interim review’ | 0.9 | 0.4 (−56.2%) | 0.6 (−41.6%) | |
| XE0re — ‘Depressed mood’ | 0.6 | 0.2 (−64.7%) | 0.4 (−19.9%) | |
| d) Female and reproductive health | 61 — ‘Contraception’ | 3.2 | 1.2 (−60.6%) | 3.0 (+12.1%) |
| 15 — ‘[Gynaecological] or [obstetric] history’ | 1.7 | 0.8 (−51.3%) | 1.3 (−17.2%) | |
| 64 — ‘(Child health care)(inf feed meth) (breast/oth feed diff age)’ | 1.1 | 0.8 (−33.0%) | 1.0 (−11.8%) | |
| K3 — ‘Disorder of breast’ | 0.2 | 0.1 (−57.9%) | 0.2 (+17.8%) | |
| 621 — ‘Patient currently pregnant’ | 0.9 | 0.7 (−26.6%) | 0.8 (−8.0%) | |
| e) Screening and related procedures | XaPVj — ‘Bowel cancer screening programme: faecal occult blood result’ | 6.4 | 3.0 (−52.1%) | 6.5 (+12.0%) |
| Xa8Pl — ‘Cervical smear’ | 4.8 | 0.2 (−95.6%) | 3.9 (+20.9%) | |
| XaRBQ — ‘NHS Health Check completed’ | 1.8 | 0.0 (−100.0%) | 0.0 (−100.0%) | |
| f) Processes related to medication | XaF8d — ‘Medication review done’ | 22.7 | 14.6 (−31.0%) | 18.7 (−8.2%) |
| XaJKW — ‘Patient understands why taking all medication’ | 0.1 | 0.0 (−100.0%) | 0.4 (+422.2%) | |
CVD = cardiovascular disease. IFCC = International Federation of Clinical Chemistry and Laboratory Medicine. O/E = on examination.